Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) |
6 Months Ended | ||
|---|---|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Jun. 30, 2026
CNY (¥)
¥ / shares
shares
|
Jun. 30, 2025
CNY (¥)
¥ / shares
shares
|
|
| Income Statement [Abstract] | |||
| Net revenues | $ 407,931 | ¥ 2,778,378 | ¥ 8,283,373 |
| Cost of revenues | (1,266,409) | (8,625,388) | (18,991,737) |
| Gross loss | (858,478) | (5,847,010) | (10,708,364) |
| Operating income (expenses): | |||
| Selling and marketing expenses | (449,521) | (3,061,642) | (2,617,584) |
| General and administrative expenses | (4,096,142) | (27,898,411) | (21,544,148) |
| Research and development expenses | (649,325) | (4,422,485) | (3,163,558) |
| Change in fair value of cryptocurrencies | (36,774,161) | (250,465,136) | 48,610,295 |
| Total operating income (expenses) | (41,969,149) | (285,847,674) | 21,285,005 |
| Profit (Loss) from operations | (42,827,627) | (291,694,684) | 10,576,641 |
| Other income (expenses): | |||
| Finance expenses | (108,690) | (740,278) | (274,189) |
| Interest expenses | (771,551) | (5,254,957) | (5,287,620) |
| Interest income | 433 | 2,951 | 12,322 |
| Change in fair value | (406,386) | (2,767,854) | |
| Change in fair value of borrowings denominated in cryptocurrencies | (18,529,435) | ||
| Other income | 303,008 | 2,063,759 | 1,724,344 |
| Other expenses | (2,688,286) | (18,309,645) | |
| Total other expenses | (3,671,472) | (25,006,024) | (22,354,578) |
| Loss before income tax provision | (46,499,099) | (316,700,708) | (11,777,937) |
| Income tax provision | |||
| Net loss | (46,499,099) | (316,700,708) | (11,777,937) |
| Less: net loss attributable to noncontrolling interests | (1,056,680) | (7,196,940) | (4,723,396) |
| Net loss attributable to Nano Labs Ltd | (45,442,419) | (309,503,768) | (7,054,541) |
| Comprehensive loss: | |||
| Net loss | (46,499,099) | (316,700,708) | (11,777,937) |
| Other comprehensive loss: | |||
| Foreign currency translation adjustment | (3,020,395) | (20,571,606) | (1,840,888) |
| Total comprehensive loss | (49,519,494) | (337,272,314) | (13,618,825) |
| Comprehensive loss attributable to noncontrolling interests | (1,053,809) | (7,177,391) | (4,722,335) |
| Comprehensive loss attributable to Nano Labs Ltd | $ (48,465,685) | ¥ (330,094,923) | ¥ (8,896,490) |
| Net loss per ordinary share attributable to Nano Labs Ltd | |||
| Basic | (per share) | $ (2) | ¥ (13.65) | ¥ (0.43) |
| Diluted | (per share) | $ (2) | ¥ (13.65) | ¥ (0.43) |
| Weighted average number of shares used in per share calculation: | |||
| Basic | 22,674,071 | 22,674,071 | 16,548,783 |
| Diluted | 22,674,071 | 22,674,071 | 16,548,783 |
| X | ||||||||||
- Definition The amount of change in fair value of borrowings denominated in cryptocurrencies. No definition available.
|
| X | ||||||||||
- Definition Amount of change in fair value crypto currencies. No definition available.
|
| X | ||||||||||
- Definition Change in fair value of derivative assets. No definition available.
|
| X | ||||||||||
- Definition Finance income (expense). No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|